Article
<i>Aotus nancymaae</i> model predicts human immune response to the placental malaria vaccine candidate VAR2CSA
2022-06-27
Abstract excerpt
Placental malaria vaccines (PMV) are being developed to prevent severe sequelae of placental malaria (PM) in pregnant women and their offspring. The leading candidate vaccine antigen VAR2CSA mediates parasite binding to placental receptor chondroitin sulfate A (CSA). Despite promising results in small animal studies, recent human trials of the first two PMV candidates (PAMVAC and PRIMVAC) generated limited cross-r...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6e93a007-7a4d-5038-bf49-445ea496c6b1
- DOI
- 10.1101/2022.06.24.497389
